Enveric Biosciences, Inc. - COM NEW (ENVB)

Historical Portfolio Holders from Q2 2022 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
506K
Holdings value Q2 2024
$307K
Value change Q2 2024
-$15.3K
Grand Portfolio weight change Q2 2024
0%
Number of holders
17
Number of buys Q2 2024
9
Number of sells Q2 2024
-8
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 506K $307K -$15.3K $0.63 17
2024 Q1 488K $488K -$82.6K $1.00 17
2023 Q4 489K $636K +$342K $1.30 14
2023 Q3 223K $518K +$50.2K $2.38 14
2023 Q2 187K $630K -$98.5K $3.37 13
2023 Q1 228K $382K +$92.4K $1.68 12
2022 Q4 173K $357K +$29K $2.07 10
2022 Q3 147K $622K -$4.67M $4.22 7
2022 Q2 1.25M $268K +$268K $0.21 1